- $351.60m
- $30.94m
- $306.91m
- 68
- 42
- 67
- 60
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 430 | 614 | 583 | 369 | 307 |
Cost of Revenue | |||||
Gross Profit | 334 | 483 | 462 | 261 | 205 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 454 | 634 | 573 | 475 | 374 |
Operating Profit | -24.3 | -19.7 | 10.5 | -106 | -67.6 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -22.5 | -17.3 | 11.3 | -104 | -53.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | -22.6 | -18 | 7.73 | -106 | -59.1 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -22.6 | -18 | 7.73 | -106 | -59.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -22.6 | -18 | 7.73 | -106 | -59.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.066 | -0.047 | 0.043 | -0.213 | -0.065 |